Biora Therapeutics, Inc., a biotech company focused on developing smart pill-based therapies, has announced a chapter 11 bankruptcy filing to facilitate a sale process aimed at strengthening its ...

Biora Therapeutics has filed for Chapter 11 bankruptcy to facilitate a sale process aimed at strengthening its balance sheet and continuing product development. The company has secured up to $10.25 ...

Biora Therapeutics (BIOR) has reached an agreement with certain of its prepetition creditors to provide financing to support a chapter 11 sale process, which will ultimately lead to a strengthened ...

Biora Therapeutics, a reputable biotech firm listed on the NASDAQ under the ticker BIOR, recently made waves in the financial world by voluntarily filing a petition on December 27, 2024, under Chapter ...

To effectuate the transaction, the Company has filed a voluntary petition under chapter 11 of the U.S. Bankruptcy Code in the District of Delaware. Throughout this process, Biora expects to operate ...

Biora Therapeutics, a biotech company developing smart pill-based therapeutic platforms, has reached an agreement with certain of its prepetition creditors (the “Lenders”) to provide financing to ...

Financial distress caused by the effects of the Covid-19 pandemic forced several fast-food restaurant chains to file for ...

To effectuate the transaction, the Company has filed a voluntary petition under chapter 11 of the U.S. Bankruptcy Code in the District of Delaware. Throughout this process, Biora expects to ...

To effectuate the transaction, the Company has filed a voluntary petition under chapter 11 of the U.S. Bankruptcy Code in the District of Delaware. Throughout this process, Biora expects to ...